Schisandrin B attenuates diabetic cardiomyopathy by targeting MyD88 and inhibiting MyD88‐dependent inflammation
W Luo, K Lin, J Hua, J Han, Q Zhang, L Chen… - Advanced …, 2022 - Wiley Online Library
Diabetes manifests as chronic inflammation and leads to the development diabetic
cardiomyopathy (DCM). Targeting key proteins in inflammatory signaling may provide new …
cardiomyopathy (DCM). Targeting key proteins in inflammatory signaling may provide new …
[HTML][HTML] Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
W Luo, K Lin, J Hua, J Han, Q Zhang, L Chen… - Advanced …, 2022 - ncbi.nlm.nih.gov
Diabetes manifests as chronic inflammation and leads to the development diabetic
cardiomyopathy (DCM). Targeting key proteins in inflammatory signaling may provide new …
cardiomyopathy (DCM). Targeting key proteins in inflammatory signaling may provide new …
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88-Dependent Inflammation.
W Luo, K Lin, J Hua, J Han, Q Zhang… - Advanced Science …, 2022 - europepmc.org
Diabetes manifests as chronic inflammation and leads to the development diabetic
cardiomyopathy (DCM). Targeting key proteins in inflammatory signaling may provide new …
cardiomyopathy (DCM). Targeting key proteins in inflammatory signaling may provide new …
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
L Wu, K Lin, J Hua, J Han, Q Zhang, L Chen… - Advanced …, 2022 - search.proquest.com
Diabetes manifests as chronic inflammation and leads to the development diabetic
cardiomyopathy (DCM). Targeting key proteins in inflammatory signaling may provide new …
cardiomyopathy (DCM). Targeting key proteins in inflammatory signaling may provide new …
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88-Dependent Inflammation
W Luo, K Lin, J Hua, J Han, Q Zhang… - Advanced science …, 2022 - pubmed.ncbi.nlm.nih.gov
Diabetes manifests as chronic inflammation and leads to the development diabetic
cardiomyopathy (DCM). Targeting key proteins in inflammatory signaling may provide new …
cardiomyopathy (DCM). Targeting key proteins in inflammatory signaling may provide new …
[引用][C] Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88-Dependent Inflammation
W Luo, K Lin, J Hua, J Han, Q Zhang, L Chen, ZA Khan… - Adv. Sci, 2022 - europepmc.org
Diabetic cardiomyopathy (DCM) is a prevalent diabetes-induced secondary complication
that leads to heart failure.[1] This unique disease entity is presented as left ventricular …
that leads to heart failure.[1] This unique disease entity is presented as left ventricular …